{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/370801511"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "UK | Posted on February 6th, 2008The company, and the drug, that has travelled furthest along this route are Tibotec/Johnson and Johnson and their as-yet-unlicensed NNRTI drug rilpivirine (TMC278)." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "nanotech-now.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/32567967"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/370801511"] } } }
